The treatment of epithelial ovarian cancer

CA Cancer J Clin. Mar-Apr 1995;45(2):88-101. doi: 10.3322/canjclin.45.2.88.

Abstract

The treatment and long-term survival of patients with ovarian cancer varies by stage. At present, five-year survival for patients with early-stage disease ranges from 50 to 95 percent, while five-year survival for patients with advanced-stage disease is less than 25 percent. Several new drugs with significant activity in advanced-stage ovarian cancer offer hope for increased long-term survival in the future. This article reviews the current and experimental approaches to the treatment of all stages of ovarian cancer.

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma / pathology
  • Carcinoma / therapy*
  • Combined Modality Therapy
  • Female
  • Humans
  • Neoplasm Staging
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / therapy*
  • Salvage Therapy
  • Treatment Outcome